Quality of life decrements in men with prostate cancer undergoing androgen deprivation therapy.
Ada Sau-Zhuen CheungCasey de RooyRudolf HoermannDaryl Lim JoonJeffrey D ZajacMathis GrossmannPublished in: Clinical endocrinology (2016)
Within 12 months, ADT is associated with clinically significant decreased QoL, particularly physical and sexual aspects, independent of the confounding effects of a cancer diagnosis or radiotherapy. As QoL is a crucial aspect of prostate cancer treatment, addressing hot flushes, sexual dysfunction and exercise may potentially improve outcomes for men undergoing ADT.
Keyphrases
- prostate cancer
- mental health
- physical activity
- radical prostatectomy
- papillary thyroid
- middle aged
- early stage
- high intensity
- squamous cell
- oxidative stress
- radiation therapy
- locally advanced
- radiation induced
- benign prostatic hyperplasia
- type diabetes
- metabolic syndrome
- resistance training
- cell therapy
- lymph node metastasis
- rectal cancer
- adipose tissue
- mesenchymal stem cells
- weight loss